Carbios SAS (ALCRB.PA) Stock Analysis & Winston Score
Carbios is a French biotech company that uses biology to recycle plastics. It has developed a process that uses enzymes — tiny natural proteins — to break down PET plastic (the kind used in water bottles and clothing fibers) back into its basic building blocks, which can then be used to make brand-new plastic. Its main customers are large consumer goods and textile companies looking for ways to use recycled materials in their products. The company earns revenue through licensing its technology to industrial partners rather than selling plastic directly, which explains its high gross margin on limited revenues. Carbios is based in France and is still in the early commercial stage, with its first industrial-scale plant under development. The core risk is that the company is not yet profitable and burns through cash while trying to prove its technology works at large scale — if it cannot attract enough licensing partners or secure financing, growth will stall.
Winston Score: 25/100 — Below Average
Below-average fundamentals — multiple weak pillars.
- Quality: Weak (1/30)
- Growth: Mixed (8/20)
- Cash Flow: Weak (0/10)
- Stability: Good (5/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
Key Facts
Price: €6.44
Market Cap: €109M
Sector: Basic Materials
Industry: Chemicals - Specialty
Exchange: Euronext Paris
